
    
      This is a multi-center study to evaluate the efficacy, safety, and persistency of solifenacin
      treatment in male patients with persistent OAB symptoms of urinary frequency and urgency
      with/without urgency incontinence who are receiving tamsulosin monotherapy for LUTS at a
      stable dose for 4 weeks in real life practice. Also proportion of patients and predictive
      factors with persistent OAB symptoms after tamsulosin monotherapy will be investigated.
    
  